Activities are intended to support regulatory testing and the Company’s planned first-quarter 2027 FDA 510(k) premarket ...

Peptide-based signaling systems continue to occupy a central role in modern biochemical inquiry, particularly in areas concerned with extracellular matrix (ECM) dynamics and structural protein ...

A new study, led by Prof. Liu from the department of pharmacy, University of Electronic Science and Technology of China, discovered that the extracellular cell matrix (ECM) could induce the drug ...

Engitix is a biotechnology company focused on discovering and developing novel therapeutics by leveraging its proprietary extracellular matrix platform. By using human tissue-derived ECM Platform ...

This isn’t science fiction. It’s emerging biology — and it might be the key to slowing, or even halting, the aging process ...

Vasa Therapeutics ("Vasa"), a clinical stage biotechnology company developing novel therapies for cardiovascular and metabolic aging, announced today that Noreen R. Henig, MD, Chief Medical Officer, ...

New research from Northwestern Medicine reveals how post-menopausal hormone shifts can weaken the brain’s memory networks.

This is the first study of its kind to examine this part of the brain and its link to estrogen.